Novo Nordisk (NVO) has cemented itself as the leader in the booming weight-loss drug market with blockbuster treatments like ...

It's being described as the best weight-loss jab yet -with results that outstrip Wegovy or Mounjaro. But anyone hoping to try ...

Morgan Stanley downgraded Novo Nordisk to underweight from equal-weight saying it sees slowing growth of its lucrative GLP-1 ...

Should the weight-loss pioneers be bracing for more lean years, then? Not necessarily. For although being first did not ...

A STAR from Gogglebox who has been on a weight loss journey just shared a snap of herself in leather trousers – and she looks ...

India embraces GLP-1 medications as a major advance in diabetes and obesity care. Experts warn these drugs require medical ...

Barnet recorded 11,510 searches for weight loss jabs in July, topping London boroughs, as an expert warns of caution over ...

Parker Waichman, a national law firm, has now filed multiple lawsuits where each Plaintiff alleged that he or she developed NAION after taking Novo ...

Barnet recorded 11,510 searches for weight loss jabs in July, topping London boroughs, as an expert warns of caution over long-term effects ...

Weight loss injections seem to be more popular, but "compounded" versions of these drugs can vary in how people access them.

With companies racing to secure GLP-1-related assets, there may be risks for moving too fast.

As India grapples with a surge in lifestyle-related illnesses, the approval of Ozempic marks more than just a new diabetes drug; it signals a shift toward modernising chronic disease care. Calling it ...